CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $2.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2026-06-30 was $2.94M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-12-31 was $1.60M, a 84.00% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-09-30 was $3.32M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2025-06-30 was -$7.52M.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2025 was -$5.38M, a 164.97% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2024 was $8.28M, a 99.11% increase from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2023 was $4.16M, a 62.13% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was $10.98M, a 67.39% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.94M 10-Q · filed 2026-07-29 | $5.95M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.93M derived: sum of 2 quarters · filed 2026-02-17 | -$2.59M derived: sum of 3 quarters · filed 2026-07-29 | -$5.38M 10-K · filed 2026-02-17 |
| 2025-09-30 | $3.32M 10-Q · filed 2025-11-06 | -$4.20M derived: sum of 2 quarters · filed 2026-07-29 | -$6.98M 10-Q · filed 2025-11-06 | $3.05M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$7.52M 10-Q · filed 2026-07-29 | -$10.31M 10-Q · filed 2026-07-29 | -$274.00K derived: sum of 3 quarters · filed 2026-07-29 | -$7.15M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$2.79M 10-Q · filed 2025-05-01 | $7.25M derived: sum of 2 quarters · filed 2026-02-17 | $373.00K derived: sum of 3 quarters · filed 2026-02-17 | -$5.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.16M derived: sum of 2 quarters · filed 2026-02-17 | $2.78M derived: sum of 3 quarters · filed 2026-02-17 | $8.28M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$6.87M 10-Q · filed 2025-11-06 | -$7.25M derived: sum of 2 quarters · filed 2025-11-06 | -$1.75M 10-Q · filed 2025-11-06 | -$6.29M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$378.00K 10-Q · filed 2025-07-31 | $5.12M 10-Q · filed 2025-07-31 | $587.00K derived: sum of 3 quarters · filed 2026-02-17 | $5.27M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $5.50M 10-Q · filed 2025-05-01 | $965.00K derived: sum of 2 quarters · filed 2026-02-17 | $5.65M derived: sum of 3 quarters · filed 2026-02-17 | $7.73M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $148.00K derived: sum of 2 quarters · filed 2026-02-17 | $2.23M derived: sum of 3 quarters · filed 2026-02-17 | $4.16M 10-K · filed 2026-02-17 |
| 2023-09-30 | $4.68M 10-Q · filed 2024-10-31 | $6.77M derived: sum of 2 quarters · filed 2024-10-31 | $8.69M 10-Q · filed 2024-10-31 | $961.00K derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $2.09M 10-Q · filed 2024-08-01 | $4.01M 10-Q · filed 2024-08-01 | -$3.72M derived: sum of 3 quarters · filed 2025-02-18 | $5.14M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.92M 10-Q · filed 2024-04-25 | -$5.81M derived: sum of 2 quarters · filed 2025-02-18 | $3.05M derived: sum of 3 quarters · filed 2025-02-18 | $10.44M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.13M derived: sum of 2 quarters · filed 2025-02-18 | $8.52M derived: sum of 3 quarters · filed 2025-02-18 | $10.98M 10-K · filed 2025-02-18 |
| 2022-09-30 | $8.86M 10-Q · filed 2023-10-26 | $16.25M derived: sum of 2 quarters · filed 2023-10-26 | $18.71M 10-Q · filed 2023-10-26 | $20.13M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $7.39M 10-Q · filed 2023-07-27 | $9.85M 10-Q · filed 2023-07-27 | $11.27M derived: sum of 3 quarters · filed 2024-02-28 | $13.69M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $2.46M 10-Q · filed 2023-04-27 | $3.88M derived: sum of 2 quarters · filed 2024-02-28 | $6.30M derived: sum of 3 quarters · filed 2024-02-28 | $6.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.84M derived: sum of 2 quarters · filed 2024-02-28 | $3.83M derived: sum of 3 quarters · filed 2024-02-28 | $6.56M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.42M 10-Q · filed 2022-10-27 | $2.42M derived: sum of 2 quarters · filed 2022-10-27 | $5.14M 10-Q · filed 2022-10-27 | $1.66M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$2.00K 10-Q · filed 2022-07-28 | $2.72M 10-Q · filed 2022-07-28 | -$754.00K derived: sum of 3 quarters · filed 2023-02-21 | -$3.44M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $2.73M 10-Q · filed 2022-05-05 | -$752.00K derived: sum of 2 quarters · filed 2023-02-21 | -$3.44M derived: sum of 3 quarters · filed 2023-02-21 | -$5.92M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$6.16M derived: sum of 2 quarters · filed 2023-02-21 | -$8.65M derived: sum of 3 quarters · filed 2023-02-21 | -$5.39M 10-K · filed 2023-02-21 |
| 2020-09-30 | -$2.69M 10-Q · filed 2021-10-28 | -$5.17M derived: sum of 2 quarters · filed 2021-10-28 | -$1.92M 10-Q · filed 2021-10-28 | -$4.10M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$2.49M 10-Q · filed 2021-07-29 | $770.00K 10-Q · filed 2021-07-29 | -$1.41M derived: sum of 3 quarters · filed 2022-02-22 | $2.29M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $3.26M 10-Q · filed 2021-04-29 | $1.07M derived: sum of 2 quarters · filed 2022-02-22 | $4.78M derived: sum of 3 quarters · filed 2022-02-22 | $4.88M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.52M derived: sum of 2 quarters · filed 2022-02-22 | $1.62M derived: sum of 3 quarters · filed 2022-02-22 | $2.94M 10-K · filed 2022-02-22 |
| 2019-09-30 | $3.71M 10-Q · filed 2020-10-29 | $3.80M derived: sum of 2 quarters · filed 2020-10-29 | $5.12M 10-Q · filed 2020-10-29 | $7.30M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $96.00K 10-Q · filed 2020-07-30 | $1.41M 10-Q · filed 2020-07-30 | $3.59M derived: sum of 3 quarters · filed 2021-02-22 | $4.89M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.32M 10-Q · filed 2020-04-30 | $3.50M derived: sum of 2 quarters · filed 2021-02-22 | $4.79M derived: sum of 3 quarters · filed 2021-02-22 | $8.33M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $3.47M derived: sum of 2 quarters · filed 2021-02-22 | $7.01M derived: sum of 3 quarters · filed 2021-02-22 | $7.64M 10-K · filed 2021-02-22 |
| 2018-09-30 | $1.30M 10-Q · filed 2019-10-31 | $4.83M derived: sum of 2 quarters · filed 2019-10-31 | $5.46M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $3.54M 10-Q · filed 2019-08-01 | $4.17M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $629.00K 10-Q · filed 2019-04-26 | |||
| 2017-12-31 | -$5.53M 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |